THERAPY OF STAGE-III (OPTIMAL) EPITHELIAL CARCINOMA OF THE OVARY WITH MELPHALAN OR MELPHALAN PLUS CORYNEBACTERIUM PARVUM - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY)

被引：26

作者：

GALL, S

BUNDY, B

BEECHAM, J

WHITNEY, C

HOMESLEY, H

LIFSHITZ, S

ADCOCK, LL

机构：

[1] DUKE UNIV,MED CTR,DURHAM,NC 27710

[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263

[3] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14627

[4] PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT OBSTET & GYNECOL,HERSHEY,PA 17033

[5] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,GYNECOL ONCOL SECT,WINSTON SALEM,NC 27103

[6] UNIV TEXAS,SW MED SCH,DIV GYNECOL ONCOL,DALLAS,TX 75202

[7] UNIV MINNESOTA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,MINNEAPOLIS,MN 55455

来源：

关键词：

D O I：

10.1016/0090-8258(86)90061-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：26 / 36

页数：11

共 11 条

[1] COX BR, 1982, J R STAT SOC B, V34, P187
[2] CREASMAN WT, 1979, CANCER TREAT REP, V63, P319
[3] MECHANISMS OF ANTI-TUMOR ACTION OF CORYNEBACTERIUM-PARVUM .1. POTENTIATED TUMOR-SPECIFIC IMMUNITY AND ITS THERAPEUTIC LIMITATIONS
DYE, ES
NORTH, RJ
MILLS, CD
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) : 609 - 620
[4] GALL SA, 1982, IMMUNOTHERAPY HUMAN, P337
[5] LEE ET, 1980, STATISTICAL METHODS
[6] MILLS CD, 1981, J EXP MED, V154, P621, DOI 10.1084/jem.154.3.621
[7] OMURA GA, 1982, ASCO C, V403, P104
[8] OMURA GA, 1981, ASCO C, V537, P470
[9] TERRY WD, 1982, IMMUNOTHERAPY HUMAN
[10] Young R C, 1975, Semin Oncol, V2, P267